For example, mutations in uL5 are observed in melanoma and T-cell acute lymphoblastic leukemia, and deletions or inactivating mutations of uL18 occurs in T-cell acute lymphoblastic leukemia and in multiple myeloma, melanoma, glioblastoma and breast cancers [35,36]. Here, RPL5 is linked to T-cell acute lymphoblastic leukemia.